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Abstract. Intra-abdominal host defense in human 
peritonitis is hampered by a severe dysfunction of 
phagocytosis due to an almost complete breakdown of 
bacteria opsonization. This defect relates to some 
opsonin consumption, but mainly to proteolytic and 
oxidative opsonin destruction. To restore and protect 
intact opsonins we have developed a clinical approach 
of intra-operative peritoneal serum application. In a 
prospective, controlled, and randomized study of 30 
patients with generalized peritonitis we have investi-
gated the impact of this adjuvant therapy on biochemi-
cal parameters and clinical features. Serum application 
induced a rise in opsonin concentration and, even 
more pronounced, opsonin function (P<001) of 
several hours' duration, leading to a distinct improve-
ment of bacteria elimination. In addition, ^-protein-
ase inhibitor ( a r P)I levels were significantly increased 
after 1 h ( P < 0 05) in the treatment group. 
The follow-up by APACHE I I scoring indicated an 
improvement in the therapy group over the whole 
observation period of 14 days. Lethality in the therapy 
group was 33% compared to 53% in controls. These 
results indicate that the intra-operative restoration of 
physiologic intra-abdominal milieu can improve bac-
teria opsonization and elimination, thus contributing 
to a favourable clinical course in abdominal sepsis. 
Keywords. Host defense, opsonins, opsonization, peri-
tonitis, proteolysis. 
Introduction 
In treating abdominal sepsis the surgical eradication of 
the source of peritonitis is the crucial prerequisite for a 
favourable outcome [1]. At the end of the surgical 
procedure, however, large quantities of bacteria 
remain in the abdominal cavity in spite of thorough 
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mechanical cleansing and lavage [2]. After therapeutic 
abdominal lavage procedures some part of the rinse 
solution is inevitably left behind. Such fluid has been 
proven to further hamper bacterial elimination prob-
ably because it dilutes the local defense components 
[3]. Thus, in the postoperative course the result of the 
competition between bacterial growth and bacteria 
elimination by physiological defense systems and 
therapeutic manoeuvers determines the patient's situa-
tion. Persisting abdominal infection in this situation 
leads to immunosuppression, endotoxinaemia and 
septic organ failure causing a high mortality [4.5]. Just 
recently, we could demonstrate pronounced patho-
logical changes of the local intra-abdominal setting in 
abdominal infection resulting in a severe impairment 
of the local defense capacity [6]. Large quantities of 
neutrophils undergo extensive stimulation by comple-
ment split products, cytokines and bacteria with a 
consecutive drastic release of both lysosomal protein-
ases and oxygen metabolites. In purulent peritonitis 
exudates proteinase inhibitor consumption became 
obvious allowing proteolytic as well as oxidative 
destruction of functional proteins, e.g. proteinase 
inhibitors, complement components and immuno-
globulins. Thus bacteria opsonization by complement 
and immunoglobulin components, a main prerequisite 
for sufficient phagocytosis, was almost abolished in 
such exudates, although the numerous phagocytes 
were highly prestimulated and intact regarding particle 
uptake and metabolic activities [6,7,8]. In order to 
restore a physiologic assembly of the intra-abdominal 
humoral defense components three main aspects have 
to be taken into account: 
1 Supplementation of intact opsonins (complement 
components and immunoglobulins). 
2 Application of proteinase inhibitors to prevent 
further proteolytic degradation. 
3 Supply of radical scavengers or oxidizable sub-
strates to detoxify oxygen metabolites and thus 
protect functional proteins. 
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Table 1. T h e M a n n h e i m e r Pe r i t on i t i s Index 
Risk factors L o a d i n g ( i f present) 
Age over 50 years 5 
Female sex 5 
Organ fa i lure 7 
N o n - r e l a t e d ma l ignancy 4 
Pre-operat ive pe r i t on i t i s ( > 24 h) 4 
P r i m a r y focus no t c o l o n 4 
DilTuse general ized pe r i t on i t i s 6 
Exudate 
clear 0 
c l o u d y - p u r u l e n t 6 
fecal " 12 
To meet all these requirements and coincidenlally 
develop an approach ready for clinical application we 
chose the local intra-abdominal application of normal 
serum. Thereby the ideally balanced composition of 
humoral defense systems, as developed by evolution 
itself, was implanted in the abdominal environment. 
The impact of this therapeutic approach for human 
abdominal sepsis on the efficiacy of local host defense 
parameters was evaluated. 
Patients and methods 
Thirty consecutive patients with abdominal sepsis 
were enrolled into this prospective, controlled, and 
randomized study. The study protocol had been 
approved by the local ethical commission. Entrance 
criteria were: diffuse peritonitis (purulent exudate in 
more than one quadrant); leukocyte count in exudate 
> 3000 fi\ '; surgical eradication of the source of 
peritonitis possible (e.g. not pancreatitis); no primary 
peritonitis (infected ascites); age over 18 years. After 
intra-operative diagnosis of a diffuse peritonitis, 
patients qualifying for the study on basis of the 
mentioned criteria were randomized into two groups. 
Surgical treatment followed standard procedures [9] 
including identical antibiotic regimens. In patients on 
risk for persistent peritonitis scheduled relaparotomies 
were performed every other day until sanitation of the 
abdominal cavity was obtained. In all cases an intra-
operative abdominal lavage was performed with 101 of 
Ringer's solution. In the therapy group one unit (about 
300 ml) of blood-group compatible normal donor 
serum (fresh frozen serum supplied by the blood bank) 
was then applied intra-abdominally to the patient. 
Testing and safety procedures for serum were the same 
as for fresh frozen plasma. Serum application was 
preferred (instead plasma) to avoid fibrin deposition. 
In control patients no sham therapy was added, 
because intra-abdominal application of inert fluids is 
known to deteriorate bacterial elimination [3]. 
Pa I ien t class ifica t ion 
By the time of the first operation scoring of severity 
was performed with the Mannheimer Peritonitis Index 
[10.11] (see Table 1) and the APACHE I I system 
[12,13,14]. A follow-up was performed with the 
APACHE I I on days 3, 7, 10 and 14, as suggested by 
the Surgical Infection Society [15]. 
Sampling procedures 
Abdominal exudate was drawn at the beginning and 
the end of the peritonitis operation and drainage 
effluate was pooled at 1,2 and 8 h postoperatively. 
These time intervals were chosen according to pilot 
studies to best follow the opsonin kinetics. Blood 
samples were drawn simultaneously and processed to 
serum and EDTA-plasma. Aliquots of the exudates 
were centrifugated at 2000 xg for 10 min and stored at 
- 7 0 C. 
Microbiology 
Exudate samples were incubated in aerobe and unaer-
obe media (culture bottles Bactec, Becton Dickinson). 
At the same time culture plates (blood agar and 
McConkey agar) were inocculated with crude exudate 
and exudate dilution 1:100. Processing and analysis 
followed microbiological standard procedures. 
Results are given as colony forming units (CFU) and 
relative CFU, that is CFU in percent of initial 
concentration. 
Pro fein con cent ra tion 
To allow for precise determination of the low protein 
concentrations in postoperative exudates a sensitive 
assay (Protein Micro Determination, Sigma) was 
employed according to the manufacturer's instruction. 
The serum standard was 7,1 g 100 m l " 1 . 
Concentration of opsonins IgG and complement C3, and 
of"a/-proteinase inhibitor (y./PI) 
Immunological quantification of all three proteins was 
performed by radial immunodiffusion on standardized 
(NOR) plates (Behringwerke, Marburg, Germany). 
For exact measurement a reading projector was 
employed. C3 plates contained C3c antibody thus 
measuring whole C3 and C3c containing fragments. 
To prevent complement activation all tests were 
performed in EDTA-exudates. The plasma standard 
was 79-9 mg 100 m l 1 . IgG plates contained polyclonal 
antihuman IgG Gamma antibody. The serum stan-
dard was 11-3 g l " 1 . For the a|PI concentration the 
serum standard was 229 mg 100 m l - 1 . 
cciPI activity 
Alphai PI function was determined as trypsin inhibi-
tion employing a specific chromogenic substrate for 
trypsin (^antitrypsin test kit, Boehringer Mannheim). 
Chemilwninescence assay for opsonic activity 
Opsonic activity was determined using a specific 
modification of a chemiluminescence assay [16]. 
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Table 2. I n d i v i d u a l pa t ient classif icat ion 
Per i ton i t i s 
P r i m a r y 
N o . A g e Sex o r i g i n exudate O p e r a t i o n surg.succ. Surv iva l 
A serum a p p l i c a t i o n ( therapy g r o u p ) 
I 87 f perf. ulcer fi s imple suture y y 
2 76 f per f .appendix fi appendec tomy y y 
3 78 r si g m a ca fe H a r t m a n n p roc . n n 
4 88 m p o l y p e c t o m y b s imple suture y n 
5 63 f gastric l y m p h o m a fi gas t rec tomy y n 
6 81 f gastric perf. P s imple suture y y 
7 78 m gastric perf. fi B 1-resection y y 
8 78 f gastric perf. fi s imple suture y y 
9 39 f endometr ios is co lonper f . fe H a r t m a n n proc . y y 
10 59 m col on perf. fe resection n n 
I I 50 f perf. ulcer fi/p B 1-resection n n 
12 89 m rectum-ca p/fe H a r t m a n n p roc . y n 
13 83 f s igma ca P resection n n 
14 48 f Mecke l ' s d i v . P i l e u m resection n n 
15 69 f d ive r t i cu l i t i s fe H a r t m a n n p roc . y y 
B no serum a p p l i c a t i o n ( c o n t r o l g r o u p ) 
1 74 m post gas t rec tomy fi/'b suture, d r a i n . n n 
2 69 f c o l o n fistula fi/p a.p., excis ion n n 
3 84 f c o l o n necrosis fi resection y y 
4 56 f intest . leakage P suture n y 
5 93 f s igma p e r f fe resection y n 
6 61 f intest. leakage fi/p resection y y 
7 75 f mesenteric ischacmia fi/p resection y y 
8 71 f co lonper f . P H a r t m a n n proc . y y 
9 69 m c o l o n ca P resection y y 
10 74 f H a r t m a n n necrosis P resection y y 
11 66 m c o l o n ca fe resection n n 
12 75 f gastric p e r f P suture n n 
13 61 r colonper f . fe H a r t m a n n proc . y y 
14 64 f d ive r t i cu l i t i s fe H a r t m a n n proc . y y 
15 51 m gastric perf. P suture y y 
fe = fecal; fi = fibrinous; b = bi le ; p pu ru l en t ; p r i m a r y surg.succ. = successful surgical s an i t a t ion o n first o p e r a t i o n ; y = ycs; n = no . 
Briefly, zymosan A was pre-opsonized by incubation 
with normal serum, patient's serum or patient's exu-
date for 15 min at 37 C respectively. The final assay 
solution contained 0 05 ml diluted EDTA blood from 
healthy donors (1:15 in phosphate-buffered saline 
(PBS)), 0-8 ml Veronal buffer and 01 ml luminol 
solution (0-7 mM), resulting in a final blood dilution of 
1:300. The reaction was started by adding 0-05 ml of 
pre-opsonized zymosan (20 mg m l " 1 ) . Chernihimines-
cence was measured with the six channel Biolumat 
LB9505 (Laboratorium Professor Berthold, Wildbad, 
Germany) and the results were integrated over 30 min 
by means of a microcomputer (Apple He). Opsonic 
activity of patient serum or exudate was expressed as 
the percentage of the value obtained using normal 
serum (=100%) [16]. 
Statistics 
Statistical analysis was performed with SPSS software. 
Figures display mean and (double) SEM. Group 
comparison for continuous variables employed the 
Wilcoxon test for related and the Mann Whitney test 
for unrelated variables. Classified parameters were 
compared by Chi square tests. 
Results 
Patient characteristics 
Individual patient classification is listed in Table 2 as to 
cause and characteristics of peritonitis, surgical pro-
cedure, success of surgical cure within one operation, 
and outcome. The two groups were comparable as to 
age. sex ratio and the underlying cause of peritonitis 
(see Table 3). The therapy group revealed a trend 
towards a higher rate of malignoma and postoperative 
peritonitis. Due to technical reasons operation time 
varied from 0-5 to 3 h. Generally it was short in simple 
suture and lavage operations but longer in anatomical 
resection. 
Scoring the severity of peritonitis during the first 
operation with the Mannheimer Peritonitis Index and 
APACHE I I both systems assigned the therapy group 
to higher scores, indicating increased risk (see Table 3). 
The follow-up by APACHE II revealed considerable 
differences between both groups especially within the 
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Table 3. G r o u p classif icat ion ( M P I = M a n n h e i m e r Pe r i lon i t i s index ; 
med ian ranee) 
M a l e : female 
Age (years) 
A P A C H E I I 
M P I 
M a l i g n a n c y ( % ) 
Pos topera t ive pe r i t on i t i s (' 
120 
1 0 0 
T h e r a p y g r o u p C o n t r o l s 
( « = I 5 ) (/?= 15) 
— • _" 
1 : 2 0 1:2-8 
67-5/42 70-1 50 
17/18 16/11 




Controls Serum Application 
Figure 1. F o l l o w - u p o f the A P A C H E I I score o n pos topera t ive days 
3. 7, 10 and 14 ( in percent o f i n i t i a l value = 100".,; di(Terence 
s iuni l icant w i t h * * / > < ( ) • ( ) I ) . 
Table 4. Class i f ica t ion o f the c l in i ca l course (median range) 
T h e r a p y g r o u p 
( / / = 1 5 ) " ^ 
C o n t r o l s 
( / / = 15) 
Re-opera t ions requ i red /pa t . 2 -513 
1 C U t rea tment (days) 20-5/53 
H o s p i t a l stay (days) 27-3/88 





first days. In controls APACHE was fairly constant 
with (median/range) 16/11 intra-operatively, 15/16 on 
day 3 and 14/11 on day 14. In the therapy group 
APACHE (median/range) was 17/18 initially, dropped 
to 10/20 on day 3 and was 12/15 on day 14. In Fig. 1 the 
course of APACHE I I is defined related to the initial 
value ( = 100'%)); on day 3 the difference between both 
groups was significant (P<00\). 
Therapy group patients required less reoperations 
for complete sanitation (mean values 20 versus 3*4) 
(see Table 4). The TCU stay and total hospital stay 
90 -
— 8 0 -
5 0 
4 0 i — 
18 36 





Controls — Serum Application 
Figure 2. S u r v i v a l rate accord ing to K a p l a n - M e i e r fo r pe r i t on i t i s 
pat ients w i t h and w i t h o u t serum a p p l i c a t i o n . 
1 0 0 
Pre lavage Post lavage 1 h 2h 8h 
Controls — Serum Application 
Figure 3. I m p a c t o f the sc rum a p p l i c a t i o n on c o l o n y f o r m i n g units 
( C F U ) in per i toneal exudate (".. o f i n i t i a l exudate concent ra-
t i o n = 100%). 
were similar in both groups. Al l time intervals date 
from the onset of peritonitis. Lethality in the study 
group was 33% compared to 53% in controls. Due to 
the sample size this difference was not significant in a 
log rank test. The difference in survival became 
obvious only 2-3 weeks after operation (see Fig. 2). 
M icroh io Iog ica I fin dings 
The number of colony forming units (CFU) in the 
exudates varied considerably. The extensive abdomi-
nal lavage led only to a moderate bacteria elimination. 
This bacteria concentration remained rather constant 
in controls. Therapy group exudates revealed a slight 
increase after 1 h, yet, after 8 h a considerably reduced 
bacteria concentration was found in this group. In Fig. 3 
32 A. G. B I L L I N G et al. 
Pre lavage Post lavage 1 h 2h 8h 
Controls Serum Application 
Figure 4. Impac t o f the serum a p p l i c a t i o n o n the overa l l p r o t e i n 
content (g d l ' ) i n per i toneal exudate . S igni f ican t difference w i t h 
* * / > < 0 - 0 l ) . 
CFU concentrations are delined in relation to the 
initial value ( = 100%). After 8 h C F U concentrations 
were 49% of initial in controls but only 3% of initial in 
serum treated patients. E. coli was predominant, 
unaerobe bacteria were present in 10%) of the patients. 
Protein content 
The median serum protein content of the control 
group (median/range) was 4-3/2-2 g d l " 1 and of the 
therapy group 40/2-4 g dl In the peritonitis exudate 
of the control group the concentration was 4-1/3-8 g 
d l " 1 , in the therapy group 3-4/4-5 g d l " 1 . In both 
groups protein content was reduced to a similar extent 
by the abdominal lavage (see Fig. 4). Serum appli-
cation resulted in a pronounced increase of protein 
concentration after 1 and 2 h, respectively. This 
increase was significantly higher tha n in the control 
group (P<001) . Eight hours post lavage the protein 
content in both groups was approximately the same. 
Complement C3 
Entrance median C3 serum concentration (median/ 
range: 52-4/24-9 mg d l " 1 ) and C3-peritonitis exudate 
concentration of the control group (49-2/74-2 mg d l " 1 ) 
exceeded insignificantly the corresponding therapy 
group concentrations (C3 in serum 51 -9/27-7 g d l " 1 ; C3 
in peritonitis exudate: 33-3/49-5 mg d l " 1 ) (see Fig. 5). 
Lavage reduced the intraperitoneal C3-concentration 
both in controls and in the therapy group. The 
postoperative C3-concentration in drainage effluate in 
controls raised up to (median/range) 21 -8/32-7 m g d l " 1 
after 1 h and remained rather stable in the further 
course. In contrast, local serum application led to a 
drastic increase of C3-concentration after 1 h followed 
by a moderate decrease after 2 h and after 8 h, 
respectively. The group differences were significant up 
to 2 h (F<0-05) post-treatment. 
Pre lavage Pos t lavage 
- O - c o n t r o l s (C3) 
— # — serum (C3) 
- - - E l - c o n t r o l s (IgG) 
serum (IgG) 
Figure 5. I m p a c t o f the serum a p p l i c a t i o n o n opson in c o n c e n t r a t i o n 
in per i toneal exudates (C3: — o — , I g G : — • — , ) . Signif icant differ-
ence w i t h * * / > < 0 - 0 I : * / > < 0 05) . 
In im unoglobulin G 
IgG serum concentrations were subnormal in all study 
patients. In the control group initial IgG serum 
concentration (median/range: 6-6/3-9 g 1 ') as well as 
IgG peritonitis exudate concentration (5*6/10-7 g 1 ') 
exceeded the corresponding concentrations found in 
the therapy group (IgG in serum 5-4/4-1 g dl ': IgG in 
peritonitis exudate 4-2/10-2 g l _ l ) . The abdominal 
lavage reduced IgG concentration both in controls and 
in the therapy group (see Fig. 5). In controls IgG 
concentration was moderately increased after 1 h and 
then remained rather constant. Local serum appli-
cation, however, led to an immediate rise of the IgG 
concentration up to (median/range) 6-2/7-2 g I " 1 after 
1 h. After 2 h the concentration was reduced to 51/8-4 
g T 1 and after 8 h to 4-2/8-2 g l " 1 . One hour after 
treatment a significant (P<00\) difference between 
both patient groups became obvious. 
Opsonic capacity 
The median opsonic capacity in serum was slightly 
subnormal, both in control (median/range: 75-5/38%) 
and in therapy patients (76-6/48%). In peritonitis 
exudates opsonic capacity in controls (6-0/27%) was 
quite different from the activity in therapy-group 
exudates (14/50%) (see Fig. 6). The intra-operative 
lavage drastically reduced these values. In controls a 
moderate postoperative recovery was observed. In 
contrast, serum application led to a pronounced 
increase of intra-abdominal opsonic capacity after 1 h. 
which persisted over the whole observation period. 
The differences between both groups were highly 
significant (P<001) throughout this post-treatment 
period. 
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6 0 
0 J — i 1 1 1 1— 
Pre iavage Post lavage 1 h 2h 8h 
Controls — Serum Application 
Figure 6. I m p a c t o f serum a p p l i c a t i o n on the opson in ac t i v i t y in 
per i tonea l exudates ( O A . i n percent o f n o r m a l serum a c t i v i t y ) . 
Signif icant difference w i t h * * / > < 0 - 0 1 ) . 
3 0 0 
!_ 2 0 0 -
E 
0 
V i \ T \\ k^^^ T r —4" 
T L \ /-H " " - f i " I 
/A T 
r i \ \ /JA - < 
\\\ /fä 
\\\ /I/ 
Pre l avage Pos t l avage 1 h 2h 8h 
- - Q - - c o n t r o l s (c^PI cone.) — A — c o n t r o l s (c^PI funct . ) 
# se rum (c^PI cone.) • — serum (c^PI func t . ) 
Figure 7. I m p a c t o f serum a p p l i c a t i o n on the X | - P I c o n c e n t r a t i o n 
( — o — ) a n d 21PI f u n c t i o n ( — • — ) in pe r i tonea l exudate . Signif icant 
difference w i t h *P< 0-05). 
a/-Proteinase ink ih it or 
Median serum concentrations of aiPI were enhanced 
to the upper limit of normal in all study patients 
(controls: (median/range) 243/198 mg d l _ l ; therapy 
group: 279/172 mg d l ~ l ) . In the exudates both groups 
revealed a similar peri-operative pattern (260/449 mg 
d l " 1 in controls and 283/345 mg d l " 1 in the therapy 
group) (see Fig. 7). By the end of the operation the 
concentration declined. The serum application pro-
voked a distinct rise of the aiPI concentration whereas 
in controls only a moderate increase was noticed. In 
the further course controls and therapy group showed 
parallel though not identical concentration patterns 
with significant differences only 1 h after serum 
application ( P < 0 05). a|PI function in peritonitis 
exudates revealed a similar course, but about 30% of 
the immunologically detected ociPI was inactive in both 
patient groups (see Fig. 7). 
Discussion 
The first hours and days after operative treatment of 
peritonitis essentially determine the further course of 
the disease. Increase of oxygenation and haemodyna-
mical stabilization indicate a favourable development, 
progressing multiorgan dysfunction characterizes a 
persistance of septic problems. A definite failure to 
eliminate the bacteria from the abdominal cavity leads 
to abscess formation or recurrent abdominal sepsis. 
Even a delay in bacteria reduction is accompanied by 
prolonged endotoxinaemia, leading to immunosup-
pression with high risk for the development of septic 
organ failure [4,5,17]. A specific clinical follow-up of 
intra-abdominal inflammation and infection in the 
early peri-postoperative hours of peritonitis has not 
been presented so far. Thus, our data provide for the 
first time detailed information about the impact of the 
operative treatment on microbiological and biochemi-
cal parameters involved in this disease and substan-
tiate a novel approach in treating peritonitis patients. 
Postoperative course without serum 
Our data give striking evidence of the great amount of 
bacteria remaining in the peritoneal cavity at the end of 
a presumably effective operation. Similar results from 
animal studies have been published by Edmiston et al. 
[2] indicating that a major part of bacteria adhere to 
mesothel and fibrin. Yet, systematical quantitative 
bacteriological controls of the intra-operative lavage 
procedure have not been published up to now in the 
relevant literature [18]. 
According to our results the lavage procedure lead 
to a more or less pronounced reduction of all proteins. 
The rather wide variation is probably due to the 
interval between lavage and the end of the operation 
(when the 'post lavage samples' were drawn), rather 
than to a different efficacy of the lavage itself. 
Although in the 'spontaneous' course (without 
serum application) a fast, moderate influx of serum 
proteins like IgG and C3 could be observed, the 
increase of activity of the opsonins IgG and C3 was 
very limited. The distinct divergence between opsonin 
concentration and function persisted, indicating rapid 
inactivation of the circulation-derived proteins in the 
peritoneal cavity. 
Impact of the local serum application on the intra-
abdominal infection 
The local application of normal serum abruptly, 
though short-termed, created a 'physiological milieu' 
in the abdominal cavity, providing the treated patients 
with a complete and intact humoral and antiproteoly-
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tic defense system. But obviously the applied serum 
underwent substantial diminution by means of resorp-
tion and exudation already during the first hours after 
intraperitoneal administration. 
We could demonstrate a trend towards an improve-
ment of bacteria elimination in the therapy group, 
which became especially obvious after 8 h. At this time 
a vigorous influx of granulocytes from the circulation 
occurs [19,20], bringing about abundant phagocytic 
capacity. Thus the conclusion seems reasonable that 
the intra-abdominal serum application provoked a 
regeneration of phagcytosis by a restitution of bacteria 
opsonization. Interestingly, the substitution of func-
tionally intact proteins was more striking than the 
mere rise of the protein concentration. Compared to 
the controls, therapy group opsonins revealed a three-
times increased function/concentration ratio, indicat-
ing that the high content of antioxidants [21] and 
proteinase inhibitors [22] in the administered serum 
protected the opsonins from oxidative and/or proteo-
lytic inactivation. In this respect, the restoration of 
aiPI levels in the peritoneal cavity due to local serum 
instillation may serve also as an indicator for the 
supplementation of other important proteinase inhibi-
tors (e.g. a2-macroglobulin). 
Impact of the local serum application on the clinical 
course 
Abdominal sepsis can develop from a considerable 
variety of underlying diseases and thus presents as a 
inhomogenous and polymorph syndrome. Therefore, 
the impact of single therapeutic additives on the 
clinical course is difficult to evaluate [8,15,23]. Besides 
the normalization of biochemical parameters any new 
therapeutic approach aims at improvement of the 
clinical course. Such benefit, however, is hard to 
define. Most peritonitis and sepsis scores are not 
constructed for follow-up purposes [24,25]. Just 
recently, the complexity of peritonitis studies has been 
discussed in extense [15]. After thorough evaluation, 
scoring with the APACHE I I system on days 0, 3, 7, 10 
and 14 has been recommended by this group of 
specialists, even though some of the APACHE I I 
parameters are subject to easy therapeutic correction 
and the index has originally been designed for an initial 
graduation only [12,13,14,26]. In this respect some 
modifications to improve continuous APACHE I I -
scoring have been proposed [27]. 
Compared to controls the APACHE II score in our 
therapy group revealed a slightly higher initial (pre-
operative) infection severity but a considerably more 
favourable further course in these patients. Persistence 
or increase of septic organ failure in the course of 
peritonitis therapy is associated with persisting or 
recurrent abdominal sepsis and it carries a poor 
prognosis [4,5]. The A P A C H E I I difference between 
our two study groups as a parameter of sepsis and 
organ failure was especially pronounced and signifi-
cant on day 3 after serum application, indicating a 
positive early impact of this therapy on relevant 
pathophysiologic features. 
Both study groups were well comparable as to age. 
sex and underlying diseases. The higher initial 
APACHE I I score and higher incidence of underlying 
malignoma in the study group indicated a higher 
severity of disease. Yet, these patients required slightly 
shorter ICU treatment and hospitalization. Lethality 
in the study group was 20% lower than that of 
controls. This difference marks a distinct positive 
trend, yet, due to the sample size, statistical signifi-
cance is not achieved. 
Lethality in abdominal sepsis is mainly caused by 
septic organ failure. Such organ impairment develops 
in the early stage or in recurrent sepsis due to 
inflammatory mediators (e.g. endotoxin. T N F , acti-
vated complement components) but can be compen-
sated for a long time by means of modern intensive 
care treatment (e.g. technical organ substitution by 
ventilation, haemofiltration etc). This phenomenon is 
reflected by our results. The positive impact of serum 
application on the (sepsis and organ failure related) 
APACHE I I score was especially pronounced in the 
early stage, whereas the difference in lethality became 
obvious only after 3 weeks. 
Unvariably, the urgent and definite surgical cure of 
the source of peritonitis is of central importance. Our 
results indicate, however, that an adjuvant therapy, 
aligned to pathophysiological mechanisms, might 
essentially contribute to a reduction of the still high 
lethality of abdominal sepsis. Our new therapeutic 
approach, that is local serum application, turned out 
to successfully ameliorate the severe impairment of 
bacteria opsonization that had previously been 
demonstrated in detail in peritonitis exudate by our 
group [6]. Although in the present study a beneficial 
effect of local serum could be demonstrated for the 
crucial initial time after operation, a prolonged 
therapy by repeated application should be of even 
more beneficial efficiency and thus deserves further 
investigation. 
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